当前位置: 首页 > 期刊 > 《医学信息》 > 2018年第3期
编号:13246909
羊水栓塞的发病机制与血清标志物研究进展(5)
http://www.100md.com 2018年1月22日 《医学信息》 2018年第3期
     [21]Frati P,Foldespapp Z,Zaami S,et al.Amniotic fluid embolism: what level of scientific evidence can be drawn? A systematic review[J].Current Pharmaceutical Biotechnology,2014,14(14):1157-1162.

    [22]Nakagami H,Kajihara T,Kamei Y,et al.Amniotic components in the uterine vasculature and their role in amniotic fluid embolism[J].Journal of Obstetrics & Gynaecology Research,2015,41(6):870-875.

    [23]Tamura N,Farhana M,Oda T,et al.Amniotic fluid embolism: Pathophysiology from the perspective of pathology[J].Journal of Obstetrics & Gynaecology Research,2017,43(4):627-632.
, 百拇医药
    [24]Hikiji W,Tamura N,Shigeta A,et al.Fatal amniotic fluid embolism with typical pathohistological,histochemical and clinical features[J].Forensic Sci Int,2013,226(1-3):e16-e19.

    [25]Legrand M,Rossignol M,Muller F,et al.Amniotic fluid embolism: an update [J].Annales Franaises Danesthèsie Et De Rèanimation,2013,32(3):189-197.

    [26]Wernet A,Luton D,Muller F,et al.Use of insulin-like growth factor binding protein-1 for retrospective diagnosis of amniotic fluid embolism in first trimester[J].Archives of Gynecology & Obstetrics,2014,289(2):461-462.
, http://www.100md.com
    [27]Legrand M,Rossignol M,Dreux S,et al.Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism[J].Critical Care Medicine,2012,40(7):14-20.

    [28]Mcdonnell NJ,Percival V,Paech MJ.Amniotic fluid embolism: a leading cause of maternal death yet still a medical conundrum[J].International Journal of Obstetric Anesthesia,2013,22(4):329-336.

    [29]Busardò FP,Frati P,Zaami S,et al.Amniotic Fluid Embolism Pathophysiology Suggests the New Diagnostic Armamentarium: β-Tryptase and Complement Fractions C3-C4 Are the Indispensable Working Tools[J].International Journal of Molecular Sciences,2015,16(3):6557-6570.
, http://www.100md.com
    [30]Fineschi V,Riezzo I,Cantatore S,et al.Complement C3a expression and tryptase degranulation as promising histopathological tests for diagnosing fatal amniotic fluid embolism[J].Virchows Arch,2009,454(3):283-290.

    [31]時春艳,丁秀萍,张梦莹,等.羊水栓塞的早期识别和团队流程化抢救[J].中华妇产科杂志,2016,51(5):397-400.

    [32]Balinger KJ,Chu LM,Hon HH,et al.Amniotic fluid embolism: despite progress, challenges remain[J].Current Opinion in Obstetrics & Gynecology,2015,27(6):398-405.
, 百拇医药
    [33]Kaur K,Bhardwaj M,Kumar P,et al.Amniotic fluid embolism [J].Journal of Anaesthesiology Clinical Pharmacology,2016,32(2):153-159.

    [34]Sultan P,Seligman K,Carvalho B.Amniotic fluid embolism: update and review[J].Current Opinion in Anaesthesiology,2016,29(3):288-296.

    [35]Nishio H,Matsui K,Miyazaki T,et al.A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase[J].Forensic Science International,2002,126(1):53-56.
, 百拇医药
    [36]Benson MD.Current Concepts of Immunology and Diagnosis in Amniotic Fluid Embolism[J].Clinical & Developmental Immunology,2012,2012(1):946576.

    [37]Stawicki SP,Papadimos TJ.Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research[J].Current Pharmaceutical Biotechnology,2014,14(14):1168-1178.

    [38]?erif Ercan,?zge Kaymaz,Yücel N,et al.Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study[J].Archives of Gynecology and Obstetrics,2012,285(3):579-584.

    收稿日期:2017-10-9;修回日期:2017-10-18

    编辑/钱洪飞, http://www.100md.com(张杰生 苏放明)
上一页1 2 3 4 5